Quercetin a Natural Therapeutic Candidate: Comparison
Please note this is a comparison between Version 2 by Dean Liu and Version 1 by Parvaneh Mehrbod.

This manuscript was provided as a comprehensive review of the anti-influenza virus effect of quercetin and its derivatives with critical evaluation. We provided different classifications and focused on viral pathogenesis, animal models, human studies, in silico and docking studies and molecular pathways of quercetin and derivatives effects comprehensively which is not included in similar articles. This review is a multidisciplinary collection of cell biology, biotechnology, drug development, and virus investigation.

  • flavonols,influenza virus,medicinal plants,quercetin derivatives
Please wait, diff process is still running!

References

  1. Rajasekaran, D., Palombo, E.A., Chia Yeo, T., Lim Siok Ley, D., Lee Tu, C., Malherbe, F., Grollo, L. Identification of traditional medicinal plant extracts with novel anti-influenza activity. PLoS ONE, 2013. 8:
  2. Bouvier, N.M., Palese, P. The biology of influenza viruses. Vaccine, 2008. 26 Suppl 4: D49-D53.
  3. Palese, P., Shaw, M., Fields Virology. Orthomyxoviridae: The Viruses and their Replication, ed. Knipe D; Howley P. 2007, Philadelphia: Lippincott Williams & Wilkins.
  4. WHO, Vaccines against influenza WHO position paper – November 2012, in The Weekly Epidemiological Record p. 461-476.
  5. Iuliano A.D., R.K.M., Chang H.H., Muscatello D.J., Palekar R., Tempia S., Cohen C., Gran J.M., Schanzer D., Cowling B.J., Wu P., Kyncl J., Ang L.W., Park M., Redlberger-Fritz M., Yu H., Espenhain L., Krishnan A., Emukule G., van Asten L., Pereira da Silva S., Aungkulanon S., Buchholz U., Widdowson M.A., Bresee J.S. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. The Lancet, 2018. 391(10127): 1285–1300.
  6. Macias AE, M.J., Chaves SS, Nealon J, Nunes MC, Samson SI, Seet BT, Weinke T, Yu H. The disease burden of influenza beyond respiratory illness. Vaccine, 2020. S0264-410X(20)31209-3.
  7. Wayan C.W.S. Putri, D.J.M., Melissa S. Stockwell, Anthony T. Newall. Economic burden of seasonal influenza in the United States. Vaccine, 2018. 36: 3960-3966.
  8. Hossein Khorramdelazad, M.H.K., Alireza Najafi, Maryam Keykhaee, Reza Zolfaghari Emameh, Reza Falak. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microbial Pathogenesis, 2020. 104554.
  9. Ding, Q., Lu, P, Fan, Y, Xia, Y, Liu, M. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan. Journal of Medical Virology, 2019. 92: 1549– 1555.
  10. Wang Ge, X.M., Ma Jingdong, Guan Jialun, Song Yang, Wen Yue, Fang Dan, Wang Muru, Tian De-an, Li Peiyuan, . Is Co-Infection with Influenza Virus a Protective Factor of COVID-19? The Lancet Infectious Diseases, 2020.
  11. Zhang AJ, L.A., Chan JF, Liu F, Li C, Chen Y, Chu H, Lau SY, Wang P, Chan CC, Poon VK, Yuan S, To KK, Chen H, Yuen KY. Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters. Clinical Infectious Diseases, 2020. ciaa1747.
  12. Thomas Drake, C.F., Antonia Ho, Lance Turtle, Clark Russell, Ewen Harrison, Calum Semple, Influenza infection in patients hospitalized with COVID-19: rapid report from CO-CIN data, in 59 SAGE Meeting
  13. Hayden, F.G. Respiratory viral threats. Current Opinion in Infectious Disease, 2006. 19: 169-178.
  14. Soema, P.C., Kompier, R., Amorij, J.-P., Kersten, G.F.A. Current and next generation influenza vaccines: Formulation and production strategies. Journal of Pharmaceutical Sciences, 2015. 94: 251-263.
  15. Barik, S. New treatments for influenza. BMC Medicine, 2012. 10:
  16. Fedson, D.S. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Infectious Diseases, 2008. 8: 571-576.
  17. Rodriguez, W.J., Hall, C.B., Welliver, R., Simoes, E.A., Ryan, M.E., Stutman, H., Johnson, G.E., Van Dyke, R., Groothuis, J.R., Arrobio, J. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial Journal of Pediatrics, 1994. 125: 129-135.
  18. Gubareva, L.V., Webster, R.G., Hayden, F.G. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrobial Agents and Chemotherapy, 2001. 45: 3403-3408.
  19. Treanor, J.J., Hayden, F.G., Vrooman, P.S., Barbarash, R., Bettis, R., Riff, D., Singh, S., Kinnersley, N., Ward, P., Mills, R.G. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza; A randomized controlled trial. Journal of the American Medical Association, 2000. 283: 1016-1024.
  20. Pathumwadee, I., Chittima, L., Thanyada, R., Arthorn, L., Maturos, M., Panita, D., Ornjira, A., Krit, C., Nopphorn, K., Pornthep, S., et al. How amantadine and rimantadine inhibit proton transport in the M2 protein channel. Journal of Molecular Graphics and Modelling, 2008. 27 342-348.
  21. Bouvier, N.M., Lowen, A.C., Palese, P. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. Journal of Virology, 2008. 82: 10052-10058.
  22. Bouvier, N.M., Rahmat, S., Pica, N. Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase. Journal of Virology, 2012. 86: 7268-7279.
  23. Ginting, T.E., Shinya, K., Kyan, Y., Makino, A., Matsumoto, N., Kaneda, S., Kawaoka, Y. Amino acid changes in hemagglutinin contribute to the replication of Ooeltamivir-resistant H1N1 influenza viruses. Journal of Virology, 2012. 86: 121-127.
  24. Hussain, M., Galvin, H.D., Haw, T.Y., Nutsford, A.N., Husain, M. Drug resistance in influenza A virus: the epidemiology and management. Infection and Drug Resistance, 2017. 10: 121-134.
  25. Lampejo, T. Influenza and antiviral resistance: an overview. European Journal of Clinical Microbiology & Infectious Diseases, 2020. 39: 1201-1208.
  26. Global Influenza Strategy 2019-2030. Wkly. Prevention, Control and Preparation 2019; 31 p.]. Available from: https://apps.who.int/iris/handle/10665/311184.
  27. Wang, J., Pathogenesis of influenza, in Radiology of Influenza: A Practical Approach, Li H, Editor. 2016, Springer Netherlands: Dordrecht. p. 9-9.
  28. Fukuyama, S., Kawaoka, Y. The pathogenesis of influenza virus infections: the contributions of virus and host factors. Current Opinion in Immunology, 2011. 23: 481-486.
  29. Oda, T., Akaike, T., Hamamoto, T., Suzuki, F., Hirano, T., Maeda, H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science, 1989. 244: 974-976.
  30. Buffington, G.D., Christen, S., Peterhans, E., Stocker, R. Oxidative stress in lungs of mice infected with influenza A virus. Free Radical Research Communications, 1992. 16: 99-110.
  31. Schwarz, K.B. Oxidative stress during viral infection: a review. Free Radical Biology and Medicine, 1996. 21: 641-6499.
  32. Akaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K., Suga, M., Zheng, Y.M., Dietzschold, B., Maeda, H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proceedings of the National Academy of Sciences of USA, 1996. 93: 2448-2453.
  33. Peterhans, E. Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation. Journal of Nutrition, 1997. 127: 962S-965S.
  34. Murphy, A.W., Platts-Mills, T.A., Lobo, M., Hayden, F. Respiratory nitric oxide levels in experimental human influenza. Chest, 1998. 114: 452-456.
  35. Cox, N.J., Hughes, J.M. New options for the prevention of influenza. New England Journal of Medicine, 1999. 341: 1387-1388.
  36. Han, S.N., Meydani, S.N. Antioxidants, cytokines, and influenza infection in aged mice and elderly humans. Journal of Infectious Diseases, 2000. 182 Suppl 1: S74-S80.
  37. De Maeyer, E., De Maeyer-Guignard, J., Interferons. 2nd ed ed. The cytokine handbook, ed. Thomson AW e. 1994, London: Academic Press. 265–288.
  38. Samuel, C.E. Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology, 1991. 183: 1-11.
  39. Pavlovic, J., Haller, O., Staeheli, P. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. Journal of Virology, 1992. 66: 2564–2569.
  40. Tough, D.F., Borrow, P., Sprent, J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science, 1996. 272: 1947-1950.
  41. Boehm, U., Klamp, T., Groot, M., Howard, J.C. Cellular responses to interferon-gamma. Annual Review of Immunology, 1997. 15: 749-495.
  42. Marrack, P., Kappler, J. Subversion of the immune system by pathogens. Cell, 1994. 76: 323-332.
  43. Dinarello, C.A., Wolff, S.M. The Role of Interleukin-1 in Disease. New England Journal of Medicine, 1993. 328: 106-113.
  44. Zhang, M., Tracey, K., cytokine handbook. 3rd ed. ed. Tumor necrosis factor, ed. Thomson AW e. 1998, San Diego: Academic Press. 517–548.
  45. Van Campen, H. Influenza A virus replication is inhibited by tumor necrosis factor-α in vitro. Archives of Virology, 1994. 136: 439-446.
  46. Hirano, T., The cytokine handbook. Interleukin-6, ed. Thomson A e. 1994, London: Academic Press.
  47. Jacoby, D.B. Virus-Induced Asthma Attacks. Journal of the American Medical Association, 2002. 287: 755-761.
  48. Ji, C., Rouzer, C.A., Marnett, L.J., Pietenpol, J.A. Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde. Carcinogenesis, 1998. 19: 1275-1283.
  49. Kakishita, H., Hattori, Y. Vascular smooth muscle cell activation and growth by 4-hydroxynonenal. Life Sciences, 2001. 69: 689-697.
  50. Palamara, A.T., Nencioni, L., Aquilano, K., De Chiara, G., Hernandez, L., Cozzolino, F., Ciriolo, M.R., Garaci, E. Inhibition of influenza A virus replication by resveratrol. Journal of Infectious Diseases, 2005. 191: 1719-1729.
  51. Fraternale, A., Paoletti, M.F., Casabianca, A., Oiry, J., Clayette, P., Vogel, J.U., Cinatl, J., Jr., Palamara, A.T., Sgarbanti, R., Garaci, E., et al. Antiviral and immunomodulatory properties of new pro-glutathione (GSH) molecules. Current Medicinal Chemistry, 2006. 13: 1749-1755.
  52. Akhand, A.A., Du, J., Liu, W., Hossain, K., Miyata, T., Nagase, F., Kato, M., Suzuki, H., Nakashima, I. Redox-linked cell surface-oriented signaling for T-cell death. Antioxidants & Redox Signaling, 2002. 4: 445-454.
  53. Nakamura, H., Nakamura, K., Yodoi, J. Redox regulation of cellular activation. Annual Review of Immunology, 1997. 15: 351-369.
  54. Saladino, R., Barontini, M., Crucianelli, M., Nencioni, L., Sgarbanti, R., Palamara, A.T. Current advances in anti-influenza therapy. Current Medicinal Chemistry, 2010. 17: 2101-2140.
  55. Liu, B., Mori, I., Jaber Hossain, M., Dong, L., Chen, Z., Kimura, Y. Local immune responses to influenza virus infection in mice with a targeted disruption of perforin gene. Microbial Pathogenesis, 2003. 34: 161-167.
  56. Mileva, M., Bakalova, R., Tancheva, L., Galabov, S. Effect of immobilization, cold and cold-restraint stress on liver monooxygenase activity and lipid peroxidation of influenza virus-infected mice. Archives of Toxicology, 2002. 76: 96-103.
  57. Mileva, M., Bakalova, R., Tancheva, L., Galabov, A., Ribarov, S. Effect of vitamin E supplementation on lipid peroxidation in blood and lung of influenza virus infected mice. Comparative Immunology, Microbiology and Infectious Diseases, 2002. 25: 1-11.
  58. Valyi-Nagy, T., Dermody, T.S. Role of oxidative damage in the pathogenesis of viral infections of the nervous system. Histology and Histopathology, 2005. 20: 957-967.
  59. Vlahos, R., Stambas, J., Selemidis, S. Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends in Pharmacological Sciences, 2012. 33: 3-8.
  60. Mileva, М. Oxidative stress as a target for medication of influenza virus infection. Acta Microbiologica Bulgarica, 2016. 3-9.
  61. Lin, L.T., Hsu, W.C., Lin, C.C. Antiviral natural products and herbal medicines. Journal of Traditional and Complementary Medicine, 2014. 4: 24-35.
  62. Aqil, F., Ahmad, I., Mehmood, Z. Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turkish Journal of Biology, 2006. 30: 177-183.
  63. Karimi, A., Majlesi, M., Rafieian-Kopaei, M. Herbal versus synthetic drugs; beliefs and facts. Journal of Nephropharmacology, 2015. 4: 27-30.
  64. Zink, T., Chaffin, J. Herbal health products: what family physicians need to know. American Academy of Family Physicians, 1998. 58: 1133-1140.
  65. Milugo, T.K., Omosa, L.K., Ochanda, J.O., Owuor, B.O., Wamunyokoli, F.A., Oyugi, J.O., Ochieng, J.W. Antagonistic effect of alkaloids and saponins on bioactivity in the quinine tree (Rauvolfia caffra sond.): further evidence to support biotechnology in traditional medicinal plants. BMC Complementary Medicine and Therapies, 2013. 13:
  66. Palhares, R.M., Gonçalves Drummond, M., Dos Santos Alves Figueiredo Brasil, B., Pereira Cosenza, G., das Graças Lins Brandão, M., Oliveira, G. Medicinal plants recommended by the world health organization: DNA barcode identification associated with chemical analyses guarantees their quality. PloS ONE, 2015. 10:
  67. Gansukh, E., Muthu, M., Paul, D., Ethiraj, G., Chun, S., Gopal, J. Nature nominee quercetin's anti-influenza combat strategy—Demonstrations and remonstrations. Reviews in Medical Virology, 2017. 27:
  68. Anand David, A.V., Arulmoli, R., Parasuraman, S. Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacognosy Reviews, 2016. 10: 84-89.
  69. Chun, O.K., Chung, S.J., Claycombe, K.J., Song, W.O. Serum C-Reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. Journal of Nutrition, 2008. 138: 753-760.
  70. Mehrbod, P., Abdalla, M.A., Fotouhi, F., Heidarzadeh, M., Aro, A.O., Eloff, J.N., McGaw, L.J., Fasina, F.O. Immunomodulatory properties of quercetin-3-O-α-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus. BMC Complementary Medicine and Therapies, 2018b. 18: 1-11.
  71. Lin, C.-F., Leu, Y.-L., Al-Suwayeh, S.A., Ku, M.-C., Hwang, T.-L., Fang, J.-Y. Anti-inflammatory activity and percutaneous absorption of quercetin and its polymethoxylated compound and glycosides: The relationships to chemical structures. European Journal of Pharmaceutical Sciences, 2012. 47: 857-864.
  72. Delgado, L., Fernandes, I., González-Manzano, S., de Freitas, V., Mateus, N., Santos-Buelga, C. Anti-proliferative effects of quercetin and catechin metabolites. Food & Function, 2014. 5: 797-803.
  73. Gansukh, E., Kazibwe, Z., Pandurangan, M., Judy, G., Kim, D.H. Probing the impact of quercetin-7-O-glucoside on influenza virus replication influence. Phytomedicine, 2016. 23: 958-967.
  74. Li, M., Xu, Z. Quercetin in a lotus leaves extract may be responsible for antibacterial activity. Archives of Pharmacal Research, 2008. 31: 640-644.
  75. Atashpour, S., Fouladdel, S., Komeili Movahhed, T., Barzegar, E., Ghahremani, M.H., Ostad, S.N., Azizi, E. Quercetin induces cell cycle arrest and apoptosis in CD133+ cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin. Iranian Journal of Basic Medical Sciences, 2015. 18: 635-643.
  76. Dajas, F. Life or death: Neuroprotective and anticancer effects of quercetin. Journal of Ethnopharmacology, 2012. 143: 383-396.
  77. Ying, H.-Z., Liu, Y.-H., Yu, B., Wang, Z.-Y., Zang, J.-N., Yu, C.-H. Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. Food and Chemical Toxicology, 2013. 52: 53-60.
  78. Choi, H.J., Song, J.H., Park, K.S., Kwon, D.H. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. European Journal of Pharmaceutical Sciences, 2009. 37: 329-333.
  79. Mehrbod, P., Ebrahimi, S.N., Fotouhi, F., Eskandari, F., Eloff, J.N., McGaw, L.J., Fasina, F.O. Experimental validation and computational modeling of anti-influenza effects of quercetin-3-O-α-L-rhamnopyranoside from indigenous south African medicinal plant Rapanea melanophloeos. BMC Complementary Medicine and Therapies, 2019. 19: 1-11.
  80. Murota, K., Terao, J. Antioxidative flavonoid quercetin: implications of its intenstinal absorption and metabolism. . Archives of Biochemistry and Biophysics, 2003. 417: 12-17.
  81. Abdal Dayem, A., Choi, H.Y., Kim, Y.B., Cho, S.-G. Antiviral effect of methylated flavonol isorhamnetin against influenza. PLoS ONE, 2015. 10:
  82. Pawlikowska-Pawlega, B., Gruszecki, W., Misiak, L., Paduch, R., Piersiak, T., B., Z., Pawelec, J., Gawron, A. Modification of membranes by quercetin, a naturally occurring flavonoid, via its incorporation in the polar head group. Biochimica et Biophysica Acta-Biomembranes 2007. 1768: 2195-2204.
  83. Ding, F., Liu, J., Du, R., Yu, Q., Gong, L., Jiang, H., Rong, R. Qualitative and quantitative analysis for the chemical constituents of Tetrastigma hemsleyanum Diels et Gilg using Ultra-High Performance Liquid Chromatography/Hybrid Quadrupole-Orbitrap Mass Spectrometry and preliminary screening for anti-influenza virus components. Evidence-Based Complementary and Alternative Medicine, 2019. 2019.
  84. Kim, Y., Narayanan, S., Chang, K.-O. Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral Research, 2010. 88: 227-235.
  85. Ibrahim, A.K., Youssef, A.I., Arafa, A.S., Ahmed, S.A. Anti-H5N1 virus flavonoids from Capparis sinaica Veill. Natural Product Research, 2013. 27: 2149-2153.
  86. Yang, Z.-F., Bai, L.-P., Huang, W.-b., Li, X.-Z., Zhao, S.-S., Zhong, N.-S., Jiang, Z.-H. Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure–activity relationship analysis. Fitoterapia, 2014. 93: 47-53.
  87. Thapa, M., Kim, Y., Desper, J., Chang, K.-O., Hua, D.H. Synthesis and antiviral activity of substituted quercetins. Bioorganic & Medicinal Chemistry Letters, 2012. 22: 353-356.
  88. Liu, A.-L., Wang, H.-D., Lee, S.M., Wang, Y.-T., Du, G.-H. Structure–activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorganic & Medicinal Chemistry, 2008. 16: 7141-7147.
  89. Lall, N., Hussein, A.A., Meyer, J.J.M. Antiviral and antituberculous activity of Helichrysum melanacme constituents. Fitoterapia, 2006. 77: 230-232.
  90. El-Kashak, W.A., Elshamy, A.I., Mohamed, T.A., El Gendy, A.E.-N.G., Saleh, I.A., Umeyama, A. Rumpictuside A: Unusual 9,10-anthraquinone glucoside from Rumex pictus Forssk. Carbohydrate Research, 2017. 448: 74-78.
  91. Eropkin, M., Gudkova, T., Konovalova, N., Shchekanova, S., Iaglovskaia, I., Eropkina, E., Kiselev, O. Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models. Eksperimental'naia i klinicheskaia farmakologiia, 2007. 70: 33-37.
  92. Bertelli, A.A.E., Mannari, C., Santi, S., Filippi, C., Migliori, M., Giovannini, L. Immunomodulatory activity of shikimic acid and quercitin in comparison with oseltamivir (Tamiflu) in an “in vitro” model. Journal of Medical Virology, 2008. 80: 741-745.
  93. Zhang, L., Cheng, Y.-X., Liu, A.-L., Wang, H.-D., Wang, Y.-L., Du, G.-H. Antioxidant, anti-inflammatory and anti-influenza properties of components from Chaenomeles speciosa. Molecules, 2010. 15: 8507-8517.
  94. Cho, W.-K., Weeratunga, P., Lee, B.-H., Park, J.-S., Kim, C.-J., Ma, J.Y., Lee, J.-S. Epimedium koreanum Nakai displays broad spectrum of antiviral activity in vitro and in vivo by inducing cellular antiviral state. Viruses, 2015. 7: 352-377.
  95. Choi, J.-G., Lee, H., Hwang, Y.-H., Lee, J.-S., Cho, W.-K., Ma, J.Y. Eupatorium fortunei and Its Components Increase Antiviral Immune Responses against RNA Viruses. Frontiers in Pharmacology, 2017. 8: 1-12.
  96. Mehrbod, P., Abdalla, M.A., Njoya, E.M., Ahmed, A.S., Fotouhi, F., Farahmand, B., Gado, D.A., Tabatabaian, M., Fasanmi, O.G., Eloff, J.N., et al. South African medicinal plant extracts active against influenza A virus. BMC Complementary Medicine and Therapies, 2018a. 18: 1-10.
  97. Chen, C., Jiang, Z.Y., Yu, B., Wu, X.L., Dai, C.Q., Zhao, C.L., Ju, D.H., Chen, X.Y. Study on the anti-H1N1 virus effects of quercetin and oseltamivir and their mechanism related to TLR7 pathway. Journal of Asian Natural Products Research, 2012. 14: 877-885.
  98. Wan, Q., Wang, H., Lin, Y., Gu, L., Han, M., Yang, Z., Zhang, Y., Ma, R., Wang, L., Wang, Z. Effects of quercetin on CDK4 mRNA and protein expression in A549 cells infected by H1N1. Biomedical Reports, 2013. 1: 766-770.
  99. Gannagé, M., Dormann, D., Albrecht, R., Dengjel, J., Torossi, T., Rämer, P.C., Lee, M., Strowig, T., Arrey, F., Conenello, G., et al. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host & Microbe, 2009. 6: 367-380.
  100. Rossman, J.S., Lamb, R.A. Autophagy, apoptosis, and the influenza virus M2 protein. Cell Host & Microbe, 2009. 6: 367-380.
  101. Jang, K.S., Kim, M.J., Oh, Y.A., Kim, I.D., No, H.K., Kim, S.D. Effects of various sub-ingredients on sensory quality of Korean cabbage kimchi. Korean Journal of Food and Nutrition, 1991. 20: 233−240.
  102. Vaidya, B., Cho, S.-Y., Oh, K.-S., Kim, S.H., Kim, Y.O., Jeong, E.-H., Nguyen, T.T., Kim, S.H., Kim, I.S., Kwon, J., et al. Effectiveness of periodic treatment of quercetin against influenza A virus H1N1 through modulation of protein expression. Journal of Agricultural and Food Chemistry, 2016. 64: 4416-4425.
  103. Choi, J.-G., Lee, H., Kim, Y.S., Hwang, Y.-H., Oh, Y.-C., Lee, B., Moon, K.M., Cho, W.-K., Ma, J.Y. Aloe vera and its components inhibit influenza A virus-induced autophagy and replication. American Journal of Chinese Medicine, 2019. 47: 1307-1324.
  104. Li, S.-W., Yang, T.-C., Lai, C.-C., Huang, S.-H., Liao, J.-M., Wan, L., Lin, Y.-J., Lin, C.-W. Antiviral activity of aloe-emodin against influenza A virus via galectin-3 up-regulation. European Journal of Pharmacology, 2014. 738: 125-132.
  105. López-Expósito, I., Castillo, A., Yang, N., Liang, B., Li, X.-M. Chinese herbal extracts of Rubia cordifolia and Dianthus superbus suppress IgE production and prevent peanut-induced anaphylaxis. Chinese Medicine, 2011. 6: 1-10.
  106. Nile, S.H., Kim, D.H., Nile, A., Park, G.S., Gansukh, E., Kai, G. Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection- In vitro and in silico biochemical and toxicological screening. Food and Chemical Toxicology, 2020. 135: 1-10.
  107. Rakers, C., Schwerdtfeger, S.-M., Mortier, J., Duwe, S., Wolff, T., Wolber, G., Melzig, M.F. Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase. Bioorganic & Medicinal Chemistry Letters, 2014. 24: 4312-4317.
  108. Duan, J., Lou, J., Zhang, Q., Ke, J., Qi, Y., Shen, N., Zhu, B., Zhong, R., Wang, Z., Liu, L., et al. A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis. PLoS ONE, 2014. 9:
  109. Lee, I.K., Hwang, B.S., Kim, D.W., Kim, J.Y., Woo, E.E., Lee, Y.J., Choi, H.J., Yun, B.S. Characterization of neuraminidase inhibitors in Korean Papaver rhoeas bee pollen contributing to anti-influenza activities in vitro. Planta Medica, 2016. 82: 524-529.
  110. Kim, D.H., Park, G.S., Nile, A.S., Kwon, Y.D., Enkhtaivan, G., Nile, S.H. Utilization of Dianthus superbus L and its bioactive compounds for antioxidant, anti-influenza and toxicological effects. Food and Chemical Toxicology, 2019. 125: 313-321.
  111. Liu, Z., Zhao, J., Li, W., Wang, X., Xu, J., Xie, J., Tao, K., Shen, L., Zhang, R. Molecular docking of potential inhibitors for influenza H7N9. Computational and Mathematical Methods in Medicine, 2015. 2015: 1-8.
  112. Liu, Z., Zhao, J., Li, W., Shen, L., Huang, S., Tang, J., Duan, J., Fang, F., Huang, Y., Chang, H., et al. Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine. Scientific Reports, 2016. 6:
  113. Yin, J., Ma, L., Wang, H., Yan, H., Hu, J., Jiang, W., Li, Y. Chinese herbal medicine compound Yi-Zhi-Hao pellet inhibits replication of influenza virus infection through activation of heme oxygenase-1. Acta Pharmaceutica Sinica B, 2017. 7: 630–637.
  114. Sadati, S.M., Gheibi, N., Ranjbar, S., Hashemzadeh, M.S. Docking study of flavonoid derivatives as potent inhibitors of influenza H1N1 virus neuraminidase. Biomedical Reports, 2019. 10: 33-38.
  115. Xu, L., Jiang, W., Jia, H., Zheng, L., Xing, J., Liu, A., Du, G. Discovery of multitarget-directed ligands against influenza A virus from compound Yizhihao through a predictive system for compound-protein interactions. Frontiers in Cellular and Infection Microbiology, 2020. 10: 1-14.
  116. Wu, W., Li, R., Li, X., He, J., Jiang, S., Liu, S., Yang, J. Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry. Viruses, 2015. 8: 1-6.
  117. Eşanu, V., Prahoveanu, E., Crişan, I., Cioca, A. The effect of an aqueous propolis extract, of rutin and of a rutin-quercetin mixture on experimental influenza virus infection in mice. Virologie, 1981. 32: 213-215.
  118. Raju, T.A.N., Lakshmi, A.N.V., Anand, T., Rao, L.V., Sharma, G. Protective effects of quercetin during influenza virus-induced oxidative stress. Asia Pac J Clin Nutr, 2000. 9: 314-317.
  119. Kumar, P., Khanna, M., Srivastava, V., Tyagi, Y.K., Raj, H.G., Ravi, K. Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection. Exp Lung Res, 2005. 31: 449-459.
  120. Savov, V.M., Galabov, A.S., Tantcheva, L.P., Mileva, M.M., Pavlova, E.L., Stoeva, E.S., Braykova, A.A. Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection. Exp Toxicol Pathol, 2006. 58: 59-64.
  121. Friel, H., Lederman, H. A nutritional supplement formula for influenza A (H5N1) infection in humans. Med Hypotheses, 2006. 67: 578-587.
  122. Davis, J.M., Murphy, E.A., McClellan, J.L., Carmichael, M.D., Gangemi, J.D. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am J Physiol-Reg I, 2008. 295: R505-R509.
  123. Kim, Y., Narayanan, S., Chang, K.-O. Inhibition of influenza virus replication by plant-derived isoquercetin. Antivir Res, 2010. 88: 227-235.
  124. Fan, D., Zhou, X., ., Zhao, C., Chen, H., Zhao, Y., Gong, X. Anti-inflammatory, antiviral and quantitative study of quercetin-3-O-β-D-glucuronide in Polygonum perfoliatum L. Fitoterapia, 2011. 82: 805-810.
  125. Choi, H.J., Song, J.H., Kwon, D.H. Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice. Phytother Res, 2012. 26: 462-464.
  126. Liu, Z., Zhao, J., Li, W., Shen, L., Huang, S., Tang, J., Duan, J., Fang, F., Huang, Y., Chang, H., et al. Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine. Sci Rep, 2016. 6:
  127. Smith, M., Smith, J.C. Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface. ChemRxiv, 2020.
  128. Omar, S., Bouziane, I., Bouslama, Z., Djemel, A. In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin converting enzyme 2 (ACE2) from natural products: Quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxy-chloroquine against COVID-19 main protease active site and ACE2. ChemRxiv, 2020.
  129. Adem, S., Eyupoglu, V., Sarfraz, I., Rasul, A., Ali, M. Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: An in silico strategy unveils a hope against Corona. Preprint, 2020.
  130. Das, S., Sarmah, S., Lyndem, S., Singha Roy, A. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 2020. just-accepted: 1-18.
  131. Mullen, W., Boitier, A., Stewart, A.J., Crozier, A. Flavonoid metabolites in human plasma and urine after the consumption of red onions: analysis by liquid chromatography with photodiode array and full scan tandem mass spectrometric detection. Journal of Chromatography A, 2004. 1058: 163-168.
  132. Zhao, J., Yang, J., Xie, Y. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: an overview. International Jof Pharmaceutics, 2019. 570:
  133. Williamson, G., Kerimi, A. Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochemical Pharmacology, 2020. 178:
More